Viatris Reaffirms FY21 Revenue Outlook, Declares Dividend - Quick Facts

While reporting financial results for the first quarter on Monday, healthcare company Viatris Inc. (VTRS) reaffirmed its total revenue guidance for the full-year 2021.

For fiscal 2021, the company continues to project total revenue between $17.2 billion and $17.8 billion. On average, 13 analysts polled by Thomson Reuters expect the company to report revenues of $17.50 billion.

The company also said its Board of Directors declared a quarterly dividend of $0.11 for each issued and outstanding share of the company's common stock, payable on June 26, 2021 to stockholders of record at the close of business on May 24, 2021.

"We see underlying strength in our business and we are reaffirming guidance for 2021, which incorporates known and potential headwinds and tailwinds for the remainder of the year. At the conclusion of the second quarter, we will be reassessing our guidance for the full year," said Michael Goettler, CEO.

The company noted that it is encouraged that their new product launches delivered revenue of $163 million for the quarter and remain on track to meet the $690 million target in new product launch revenue for the year. It is also on track to realize approximately $500 million of cost synergies this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. reported Tuesday narrower net loss in its second quarter with strong growth in revenues. The company also generated strong order growth. Looking ahead, the company reiterated its outlook for adjusted earnings per share, while increased its 2021 outlook for Industrial free cash flow range. In pre-market activity on NYSE, GE shares were gaining around 4 percent. The U.S. Food and Drug Administration announced recall of Old Soul's Farms LLC's certain leafy green products as well as Excalibur Seasoning Co.'s Haen Meats Seasoning Blend, citing potential contamination with Listeria monocytogenes, an organism. Consumption of food contaminated with L. monocytogenes can cause listeriosis, a serious infection and sometimes fatal infections. Tobacco giant Philip Morris International plans to stop selling cigarettes in the United Kingdom in the next decade, according to its CEO Jacek Olczak. In an interview with the Daily Mail Sunday, Olczak said the sales of the company's most popular product Marlboro cigarettes will also be stopped. The move is said to be part of the company's plan to phase out traditional tobacco products.
Follow RTT